Anika Therapeutics | 営業経費





営業経費 変化する 日付
Abbott USD 9.21B 17M 2025-12
Agenus USD -274.14M 80.46M 2025-09
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 223.22M 10.86M 2025-12
Enanta Pharmaceuticals USD 79.28M 14.26M 2025-06
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
Heron Therapeutics USD 38.47M 4M 2024-09
Insmed USD 403.69M 42.4M 2025-09
Integra LifeSciences USD 1.04B 620.66M 2025-09
Intrexon USD 61.56M 26.1M 2024-06
J&J USD 18.97B 2.38B 2025-12
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
MacroGenics USD 67M 8M 2025-09
Merit Medical Systems USD 341.54M 6.11M 2025-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 10.51B 1.21B 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
Stryker USD 5.2B 505M 2025-12
Surmodics USD -245.35M 363.49M 2024-09
Veracyte USD 108.76M 7.09M 2025-09
Xencor USD 68.52M 8.26M 2025-09
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12


Anika Therapeutics 営業経費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.